NICHD conference on kernicterus: Research on prevention of bilirubin-induced brain injury and kernicterus: Bench-to-bedside - Diagnostic methods and prevention and treatment strategies

Journal of Perinatology

Volumn 24, Issue 8, 2004, Pages 521-525

  Stevenson, David K ^a,e   Wong, Ronald J ^a   Vreman, Hendrik J ^a   McDonagh, Antony F ^b   Maisels, M Jeffrey ^c   Lightner, David A ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d UNIVERSITY OF NEVADA   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; GLUCURONOSYLTRANSFERASE; HEME OXYGENASE INHIBITOR; MESOPORPHYRIN CHROMIUM; MESOPORPHYRIN TIN; METALLOPORPHYRIN; PORPHYRIN DERIVATIVE; PORPHYRIN ZINC; PROTOPORPHYRIN ZINC; UNCLASSIFIED DRUG;

ACID BASE BALANCE; BILIRUBIN BLOOD LEVEL; BRAIN INJURY; CHEMOPROPHYLAXIS; COLORIMETRY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG ABSORPTION; DRUG MECHANISM; HEALTH CARE ORGANIZATION; HUMAN; KERNICTERUS; LIGHT EMITTING DIODE; NEWBORN; NEWBORN JAUNDICE; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PHOTOTHERAPY; PHOTOTOXICITY; TREATMENT PLANNING; UNITED STATES;

BILIRUBIN; HUMANS; INFANT, NEWBORN; KERNICTERUS;

EID: 4344625849     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211124     Document Type: Conference Paper

References (23)

1. Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem 1996;42:869-73.
2. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61:748-55.
3. Weiss JS, Gautman A, Lauff JJ, et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983;309:147-50.
4. McDonagh AF, Palma LA, Lauff JJ, Wu TW. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest 1984;74:763-70.
5. McDonagh AF, Lightner DA. Like a shrivelled blood orange' - bilirubin, jaundice, and phototherapy. Pediatrics 1985;75:443-55.
6. Ahlfors CE. Measurement of plasma unbound unconjugated bilirubin. Anal Biochem 2000;279:130-5.
7. Yamanouchi I, Yamauchi Y, Igarashi I. Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 1980;65:195-202.
8. Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med 2003;31:81-8.
9. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:E17-25.
10. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14.
11. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;108:31-9.
12. McDonagh AF, Lightner DA. Phototherapy and the photobiology of bilirubin. Semin Liver Dis 1988;8:272-83.
13. Tan KL. Efficacy of fluorescent daylight, blue, and green lamps in the management of nonhemolytic hyperbilirubinemia. J Pediatr 1989;114: 132-7.
14. Vreman HJ, Wong RJ, Murdock JR, Stevenson DK. In vitro efficacy of an LED-based phototherapy device (neoBlue™) compared to traditional light sources. Pediatr Res 2003;53:400A.
15. Aouthmany MM. Phototherapy increases hemoglobin degradation and bilirubin production in preterm infants. J Perinatol 1999;19:271-4.
16. Wong RJ, Vreman HJ, Stevenson DK. (Metallo)porphyrin inhibitors of heme oxygenase also inhibit lipid peroxidation (LP). Pediatr Res 2000;47:465.
17. Appleton SD, Chretien ML, McLaughlin BE, et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 1999;27:1214-9.
18. Vreman HJ, Ekstrand BC, Stevenson DK. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 1993;33:195-200.
19. Zhang W, Contag PR, Hardy J, et al. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J Mol Med 2002;80:655-64.
20. Wong RJ, Abate A, Dennery PA, Vreman HJ, Contag CH, Stevenson DK. Intestinal absorption of metalloporphyrins and systemic effects on heme oxygenase. Pediatr Res 2003;53:400A.
21. Vreman HJ, Wong RJ, Stevenson DK. Alternative metalloporphyrins for the treatment of neonatal jaundice. J Perinatol 2001;21(Suppl 1):S108-13.
22. Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 1994;93:1.
23. Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 1999;103:1-5.